CORONA Remedies Limited

NSE: CORONA · Unclassified

₹2,441.10+2.58%06 Nov 2026

Ask the data

Instant answers about CORONA Remedies Limited — computed from its filings, no language model

Market cap₹14,930 cr

Current price₹2,441.10

High / Low₹2,441 / ₹1,348

P/E72.1

P/B18.54

Book value₹131.6

ROE25.7%

ROCE31.1%

Debt / equity0.12

Dividend yield—

EPS (TTM)₹33.85

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY26
Revenue	1,403
EBITDA	293
Operating margin	20.9%
Interest	7
Depreciation	38
Profit before tax	240
Tax	55
Net profit	185
EPS ₹	30.27
Operating cash flow	229
Capex	174
Dividend paid	0
Total assets	1,205
Equity	747

Quarterly performance

last 5 quarters · ₹ crore

	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	361	342	353	422	441
Operating profit	78	83	62	93	96
Operating margin	21.7%	24.3%	17.6%	22.0%	21.7%
Other income	2	2	4	3	2
Interest	2	2	1	3	3
Depreciation	9	9	10	13	15
Profit before tax	70	55	55	80	81
Tax	17	14	9	20	20
Net profit	52	41	45	60	60
EPS ₹	8.55	6.75	7.41	9.83	9.86
Revenue YoY	—	—	—	—	22.2%
Profit YoY	—	—	—	—	15.3%

Returns & margins

trailing-twelve-month, per quarter

	JUN '26	SEP '26
ROE	26.6%	25.7%
ROCE	30.1%	31.1%
Net margin	13.5%	13.3%
EBITDA margin	21.4%	21.4%
Debt / equity	0.19	0.12
Interest coverage	34.93	32.95
Asset turnover	1.23	1.25

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '25	MAR '26	SEP '26
Share capital	61	61	61
Other equity / reserves	598	686	744
Total equity	660	747	805
Borrowings	40	143	95
Current liabilities	242	361	333
Non-current liabilities	75	97	109
Total assets	977	1,205	1,247
Property, plant & equipment	200	291	425
Capital work-in-progress	205	143	22
Investments	26	26	26
Inventories	107	125	171
Receivables	160	146	171
Cash & equivalents	2	2	2

Cash flow

annual · ₹ crore · line = free cash flow

	FY26
Cash from operations	229
Cash from investing	-256
Cash from financing	25
Capex	174
Free cash flow	55
Dividends paid	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹425 cr34%

CWIP

₹22 cr2%

Investments

₹26 cr2%

Inventories

₹171 cr14%

Receivables

₹171 cr14%

Cash & equivalents

₹2 cr0%

Other assets

₹430 cr35%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
CORONA Remedies Limited	14,930	2,441.10	72.1	18.54	25.7%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+19.6%

6 months+40.1%

1 year—

3Y CAGR—

5Y CAGR—

10Y CAGR—

50-day avg₹2,120.82

200-day avg₹1,845.53

RSI (14)84

FAQs

What is the share price of CORONA Remedies Limited?

CORONA Remedies Limited (CORONA) closed at ₹2,441.10 on NSE on 06 Nov 2026.

What is the market cap of CORONA Remedies Limited?

₹14,930 crore at the latest close.

What is the P/E ratio of CORONA Remedies Limited?

72.1, on trailing-twelve-month earnings from its filings.

How fast is CORONA Remedies Limited growing?

CORONA Remedies Limited: Latest-quarter revenue is up 22.2% year on year, profit up 15.3%.

How profitable is CORONA Remedies Limited?

On a trailing-twelve-month basis return on equity is 25.7%, return on capital employed 31.1%, operating margin 21.4%, net margin 13.3%.

How much debt does CORONA Remedies Limited have?

CORONA Remedies Limited is lightly geared: debt to equity is 0.12 with borrowings of ₹95 cr against cash of ₹2 cr (balance sheet of 2026-09-30). Operating profit covers interest 32.9 times.

Financials parsed from CORONA Remedies Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '25, annual from FY26, balance sheet from Sep '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.